News

Smoking, alcohol consumption and betel nut chewing are some of the lifestyle factors that have been linked to head and neck ...
Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...
Merck & Co.’s Keytruda has become the first immunotherapy approved by the FDA to be used around surgery to treat resectable ...
Reduce your other risk factors. Tobacco and alcohol use are some of the strongest lifestyle risk factors for head and neck cancer. In a recent study, tobacco use increased the risk of developing ...
A 56-year-old American man was diagnosed with stage 4 head and neck cancer after noticing a weird, painless boil on his ...
MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...
The purge of probationary federal workers included skilled lab personnel who would have finalized a customized cell ...
The KEYNOTE-689 study showed pembrolizumab with standard of care significantly improved outcomes for resectable HNSCC, ...
Keytruda was approved for locally advanced head and neck cancer before and after surgery, showing improved event-free ...
Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...